What is a Special Interest Group (SIG)?
|
|
- Samantha Thomas
- 6 years ago
- Views:
Transcription
1 PATIENT REPORTED OUTCOMES RESEARCH SPECIAL INTEREST GROUP Open Meeting 20 th Annual European Congress November 6, 2017 Glasgow, Scotland What is a Special Interest Group (SIG)? Member-driven group interested in a specific topic SIG membership is open to all ISPOR members PURPOSE Monitor & share information related to the topic To engage ISPOR members in projects that advance health economics and outcomes research and the use of this research in health care decisions 2 1
2 New Special Interest Group Structure Special Interest Group Chair, Past Chair, Chair-elect Key Project Working Group* (Co-chairs) (i.e. manuscript) Member Engagement Working Group (Co-chairs) (i.e. Webinars SIG Membership * Working group formally known as Leadership Group 3 Governance Chair elect Chair Past Chair (chair will move to this position next year) Each chair serves a 1-year term Working Group Co-Chairs Key Project Serve until the project is complete (average 24 months) Member Engagement Projects Serves for at least the year To be considered for chair positions please submit your current CV to ttesoro@ispor.org 4 2
3 Chair, Past Chair, Chair-elect Responsibilities Provide overall direction and leadership Identify the topics the SIG members would like to address Work with the Working Group co-chairs to ensure the timeliness of the key project Categorizing topics into long, short term projects Address any issues within the group Identify the appropriate platforms for delivery 5 Chair, Past Chair, Chair-elect Responsibilities Provide quarterly updates to the SIG membership Report the progress of the SIG projects Recruit new SIG members Current activities, new developments in field via the yearly business and project plan to HSPC 6 3
4 Working Group The Working Group provides leadership and contributes to the development of the project Each SIG will have at least 2 Working Groups Key Project (i.e. Manuscript in Value in Health or Value Outcomes & Spotlight, Short Courses) Member Engagement (i.e. webinars, virtual issue panel, workshop, etc.) SIG membership is open to all stakeholders in all geographic areas 7 Key Project Working Group Manuscript: Value in Health or Value Outcomes & Spotlight Short Courses Tools for Website The Working Group Co-chairs will be responsible for: Leading the project and teleconference Ensuring adherence to ISPOR processes and working group deadlines Address any conflicts or issues 8 4
5 Member Engagement Working Group Webinar/speaker Journal club Technical workshop series Presentations on Working Group products ISPOR forums on Key Project, or other presentations Other organization presentations Encouraged to be creative The Working Group Co-chairs will be responsible for: Work with SIG chairs to identify member engagement topics Identifying speakers, articles, topics for member engagement activities Ensuring that all member engagement activities take place 9 SIG Benefit Share and exchange information with other members from different stakeholder groups Networking Collaborating with HEOR experts Contribute to the Science Develop ISPOR educational content 10 5
6 Publication Ethics Ten years ago, the ISPOR Board of Directors instituted a Scientific and Health Policy Group publication rule: No member of an ISPOR Task Force or Special Interest Group should publish any material from an upcoming report, public presentation, or project deliverable without first consulting the larger group for permission prior to submission and publication." ISPOR Code of Ethics: Members should NOT publish any material relating to the activities of an ISPOR Task Force, Special Interest Group or other ISPOR group at any stage, without first consulting fellow group members / co-authors for permission. 11 QUESTIONS? Thank You 6
7 Next Steps Identify: Interest in Topic List of Potential Research Topics Which topics are: Key Project Member Engagement Project Submit proposal to HSPC 13 Differentiating patient engagement from PRO goals (Bryan Bennett) Patient engagement goal To facilitate the involvement of patient representatives in the research process. The group will define key terms, and examine existing theoretical frameworks of patient engagement in health research and outcomes process. Patient reported outcomes goal To identify new and best methodological advances in the field of patient reported outcome instrument development and use. The group will liaise with patient engagement group in terms of patient involvement but has a distinct focus on implementation and methods. It may also produce materials that could be of use in other psychometric clinical outcomes assessments. 14 7
8 Potential Research Topics 1. RW data and PRO (Angela Rylands; 10 mins) 2. PRO results simplification (Katja Rüdell; 10 mins) 3. PRO analyses and psychometric methods (Stacie Hudgens; 10 mins) 15 Key Projects of the PRO group 1. RW data and PRO (Angela Rylands; 10 mins) 2. PRO results simplification (Katja Rüdell; 10 mins) 3. PRO analyses and psychometric methods (Stacie Hudgens; 10 mins) 16 8
9 Who is talking about patient centred outcomes (PCO) data collected via real work research (Angela Rylands) Developing a Framework for Regulatory Use of Real- World Evidence Conference theme Embracing Complexity: Using PROs to Generate RWE Why is there increasing interest in PCO in the real world? Patients: - Track symptoms over time - In turn can benefit patients quality of life - Lengthen survival - Shared decision making Patients Physicians Physicians: - Clinical effectiveness from the patients perspective - Enhance patient-clinician communication -Increased data for comparative effectiveness research Payers: - Reduce emergency department use - Increased data for resource use or cost-benefit assessments Payers Regulators Regulators: - Use of novel RWE trials and methodologies - Want to understand role of RW data to measure drug effectiveness 9
10 What challenges are there with PCO data in the real world? Standards for PCO in RW to define; appropriate frequency of data collection minimising missing data rules for analysing PCO data in RW User Guides for PCO data collection in the RW Add to the ISOQOL 2011 guidelines for implementing PROMs in clinical practice Systematically integrate PCO data collection into routine clinical care / RW Standardisation of methods for integrating PCO instruments into clinical workflow PCO data collection via online patient portals? Information in a flexible user-configurable format? Education and incentives around collecting PCO data in the RW PCO data interpretation for clinicians / health care providers how do providers with the flow of information Define of best in class PCO instruments in RW what constitutes the responsiveness of a PRO in a RW stetting? Key project 1 PCO in the Real World This key project aims to address the use of PCO in real world studies. It is necessary to identify the role of PCO in RW studies and to determine if there are any methodological differences in the real world verses clinical trials. The deliverables from this key project would include the following: Envisaged steps: Submission of a forum at a forthcoming ISPOR conference to discuss the use of PCO in RWE Development of a PCO RWE implementation guidelines that will aggregate the issues around RWE or clinical use of PRO and inclusion in medical records. Development of a manuscript for submission to Value in Health setting the standards for the use of PCO data collection in RW research. 10
11 Simplification and reduction of PRO results complexity (Katja Rüdell) PRO data is very complex (similar to nutritional values) There are many different components to consider (the absolute values at baseline, the distribution and change over time) ISPOR presentation from 2016 lots of different tools available to researchers so it gets very difficult for the average researcher consumer to understand what it means Not all teams or consumers will have a PRO researcher at hand to help them interpret the data. What to do next? Nutritional intake is equally complex Key project 2 Simplifying PRO results This key project aims to simplify PRO data to such an extent that it becomes accessible to patients, researchers and clinicians Envisaged steps: A) Engaging with patients/caregivers to discuss what information they would expect to see in findings from clinical trial results. We envisage this could be done through the following ways: A brief literature review to identify currently how information is presented to patients. Conduct online focus groups to identify what information is most relevant and useful to patients that considers: a) Patient Reported Content that should be displayed on the label/ in the product description or in manuscripts 1. Symptoms, 2. Side effects, 3. Functioning / QOL and/ or 4. Intrusiveness /complexity of the medical treatment). b) Patient relevant therapeutic effects 1. Onset of effect (how long will it take to see the onset on symptoms or side effects?), 2. Duration of effect (how long will I experience the benefit of symptom relief?) 3. Strength of effect (will this medication help me have a meaningful improvement?) 11
12 Key project 2 B) The development of education materials for patients and caregivers to better understand patient reported effects that are observed from a trial within a quick study of a label or a research publication. Graphical displays that speak to this will be tested with patients. It is envisaged that this work will aim to simplify the information and make symptoms, side effects, functioning and quality of life findings accessible to patients, caregivers and payers. We will partner with a group of caregivers and patients initially to discuss their evidence requirements and provide solutions that address these issues. The meetings will be held as webinars so that patients from different countries can attend. Development of a manuscript outlining the activities a. and b. above for submission in Value in Health Development of PRO results template slide deck for distribution amongst ISPOR members Key project 3 Statistical and Psychometric Analytic Solutions (Stacie Hudgens) This key project aims to synthesize cross-sectional and longitudinal statistical and psychometric methods into a best practice guide for analysis and visualization of patient outcomes data Stacie is Chief Executive Officer and Strategic Lead at Clinical Outcomes Solutions with over 20 years of Pharmaceutical industry, academic and consulting experience and has a specialism in Quantitative Science. She is currently the co-chair of the Psychometric Special Interest Group at ISOQOL. 12
13 Key project 3 Statistical and Psychometric Analytic Solutions (Stacie Hudgens) Current Guideline Documents COSMIN (COnsensus-based Standards for the selection of health Measurement Instruments) PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) MOOSE (Meta-analysis Of Observational Studies in Epidemiology) STARD (Standards for Reporting Diagnostic Accuracy) CONSORT (CONsolidated Standards Of Reporting Trials) Lacks guidance on reporting of PROs PRO data increasingly used for clinical decision making as well as comparative effectiveness, health policy, and reimbursement decisions Trials that incorporate PROs as an outcome should therefore be designed, analysed, and reported well. Key project 3 Statistical and Psychometric Analytic Solutions (Stacie Hudgens) Current Guideline Documents CONSORT PRO 2013 extension of the CONSORT 2010 checklist to facilitate optimal reporting of RCTs in which PROs are the primary or secondary endpoints Developed based on the methodological framework for guideline development proposed by the EQUATOR network (Enhancing the QUAlity and Transparency Of health Research) Provides guidance for authors of trials describing PROs Five CONSORT PRO checklist items 1) PROs identified as 1 or 2 outcomes in the abstract 2) Description of PRO hypotheses and relevant domains provided 3) Evidence of PRO reliability and validity be provided or cited 4) Statistical approaches for dealing with missing data explicitly stated 5) PRO-specific limitations and generalizability to other populations and clinical practice be discussed Calvert M, Blazeby J, Altman DG, et al. Reporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension. JAMA 2013; 309(8):
14 Key project 3 Statistical and Psychometric Analytic Solutions (Stacie Hudgens) Best practice guide for analysis and visualization of patient outcomes data Envisaged steps: Conduct a brief literature review of published statistical and clinical trial patient outcomes data to identify statistical and psychometric parameters commonly used to present as well as interpret data Based on findings from the literature review, conduct a web-based survey circulated to ISPOR membership Prepare data visualization graphics to guide the interpretation of complex analyses for non-statisticians and psychometricians used in published clinical trial results Outputs: Development of best practice guide(s) for analysis and interpretation of patient outcomes data (manuscript or slide deck for ISPOR distribution) one for statistical analysis and one for psychometric analysis Member Engagement Project The PRO working group has identified 3 key projects which will all require ISPOR member use and engagement. It is therefore currently envisaged that member engagement will be driven from these projects. Additionally in the field of PRO research the use of electronic devices to collect PRO data and translation is very crucial for efficient and robust data collection we therefore envisage that we will also collaborate with CPATH consortiums epro group and run webinars on new and innovative translation methods as well as epro advances. (Sue Vallow will act as liaison with CPath) 28 14
15 Interested in participating in the leadership group forming the SIG projects please contact Theresa Tesoro 29 15
Nutrition Economics SPECIAL INTEREST GROUP
Nutrition Economics SPECIAL INTEREST GROUP Open Meeting 20 th Annual European Congress November 7, 2017 Glasgow, Scotland NUTRITION ECONOMICS SPECIAL INTEREST GROUP 07:30 07:35 Welcome 07:35 07:50 Status
More informationDissemination experiences from CONSORT and other reporting guidelines
Dissemination experiences from CONSORT and other reporting guidelines Doug Altman Centre for Statistics in Medicine, Oxford EQUATOR Network [Altman and Goodman, JAMA 1994] 2 Passive
More informationEHR Developer Code of Conduct Frequently Asked Questions
EHR Developer Code of Conduct Frequently Asked Questions General What is the purpose of the EHR Developer Code of Conduct? EHR Association (the Association) members have a long tradition of working with
More informationSpain Carme Pinyol Natividad Calvente Pedro Gómez Cristina Espinosa Carlos Martín Paloma González Ana Becerro de Bengoa José Vicente Galindo
Chapter name President President-Elect Past President Secretary Treasurer Director Director Director Other, non-board positions (please list if applicable) When are elections held for the Chapter Board?
More information2. The role of CCG lay members and non-executive directors
CCG Lay Members, Non-Executive Directors and STP Governance and Engagement 1. Introduction Report from network events organised by NHS England and NHS Clinical Commissioners in February 2017 This briefing
More informations, website, meetings, seminars, conferences
Chapter name President President-Elect Past President Secretary Treasurer Director Director Director Other, non-board positions (please list if applicable) When are elections held for the Chapter Board?
More informationIntegrating the Patient Perspective Into Value Frameworks
Integrating the Patient Perspective Into Value Frameworks Avalere Health An Inovalon Company August, 2017 Speakers and Agenda Josh Seidman, PhD Senior Vice President jjseidman@avalere.com @jjseidman 1.
More informationINVOLVING YOU. Personal and Public Involvement Strategy
INVOLVING YOU Personal and Public Involvement Strategy How to receive a copy of this plan If you want to receive a copy of Involving You please contact: Elaine Campbell Corporate Planning and Consultation
More informationEngaging with our stakeholders
Engaging with our stakeholders Report to: Board Date: 27 June 2014 Report by: Report No: Jenny Copland, Senior Communications Adviser Agenda Item: 6.3 PURPOSE OF REPORT To propose a format and processes
More informationHEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018
HS/S5/18/14/A HEALTH AND SPORT COMMITTEE AGENDA 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 The Committee will meet at 10.00 am in the James Clerk Maxwell Room (CR4). 1. Scottish Health Council Review:
More informationPOSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION
POSITION DESCRIPTION Position Title: Location: Research Coordinator Clinical Trials National Secretariat, Brisbane-based Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) Reporting Relationships:
More informationMeta-analysis of safety thoughts from CIOMS X
CIOMS Working Group X Meta-analysis of safety thoughts from CIOMS X Stephen.Evans@Lshtm.ac.uk Improving health worldwide www.lshtm.ac.uk Evans: ENCePP CIOMS Meta Analysis 1 Acknowledgements, conflicts,
More informationPatient-Centered Endpoints in Oncology
Patient-Centered Endpoints in Oncology SIXTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP April 29-30, 2015 Silver Spring, MD Disclaimer The views and opinions expressed in the following slides
More informationPatient-Centered Measurement: Innovation Challenge Series
Patient-Centered Measurement: Innovation Challenge Series Learning Collaborative 2018 Webinar Thursday, March 1, 2018 1 Hala Durrah, MTA Patient Family Engagement Consultant, Speaker & Advocate 3 2017-18
More informationClinical Trial Endpoints from Mobile Technology: Regulatory Considerations September 29, 2016
Clinical Trial Endpoints from Mobile Technology: Regulatory Considerations September 29, 2016 Elektra J. Papadopoulos, MD, MPH Clinical Outcome Assessments Staff Office of New Drugs Center for Drug Evaluation
More informationWORLD FEDERATION OF ENGINEERING ORGANIZATIONS
DRAFT World Federation of Engineering Organizations Committee on Engineering and the Environment Teleconference Meeting #4 July 5, 2011 Meeting Summary 1. WELCOME AND INTRODUCTIONS The following persons
More informationREGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in
More informationProgress from the Patient-Centered Outcomes Research Institute (PCORI)
Progress from the Patient-Centered Outcomes Research Institute (PCORI) Anne Beal, Chief Operating Officer of the Patient-Centered Outcomes Research Institute Sharon-Lise Normand, Vice Chair, Methodology
More informationPort of Portland Hillsboro Airport Master Plan Update Planning Advisory Committee Charter
Port of Portland Hillsboro Airport Master Plan Update Planning Advisory Committee Charter Charter Purpose The purpose of this charter is to define the role of the Planning Advisory Committee () within
More informationReporting guidelines
Reporting guidelines Diaa E.E. Rizk Editor, International Urogynecology Journal rizk.diaa@gmail.com IUGA 2015 Nice Workshop #7 How to publish and review 9 June 2015 Aim of reporting guidelines Standardize
More informationReal world Outcomes across the AD spectrum for better care: Multi-modal data Access Platform
Real world Outcomes across the AD spectrum for better care: Multi-modal data Access Platform Catherine Reed, Lilly on behalf of ROADMAP consortium 3 rd Nordic conference on Real World Data, 28-29 November
More informationStrategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value
Strategy 2017-20 Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority Agenda item 7 Paper number HFEA (11/05/2016)
More informationVolunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland
NG11-07 ing in NHSScotland Developing and Sustaining ing in NHSScotland Outcomes The National Group for ing in NHS Scotland agreed the outcomes below which formed the basis of the programme to develop
More informationChapter Quality Network (CQN) Practice Improvement to Address Adolescent Substance Use Project Chapter Application
Chapter Quality Network (CQN) Practice Improvement to Address Adolescent Substance Use Project Chapter Application Chapter Name Names of Chapter Leadership President: Vice President: Executive Director:
More informationCall for Applications
2013 Knowledge Synthesis Grant Program Call for Applications Program Guidelines Overview Technology Evaluation in the Elderly Network (TVN or the Network) is a new network funded by the Government of Canada
More informationOncology Special Interest Group
Oncology Special Interest Group Open Meeting Tuesday, 10 November 2015 ISPOR 18 th Annual European Congress MiCo Milano Congressi, Milan, Italy Compounds in Development for Top 10 Therapeutic Areas a Number
More informationThe Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework
The Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework A position paper from the Directors of the GISRS WHO Collaborating
More informationMultisectoral action for a life course approach to healthy ageing
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY Provisional agenda item 14.4 21 March 2014 Multisectoral action for a life course approach to healthy ageing 1. The attached document EB134/19 was considered and noted
More informationDeveloping a Public Representative Network
Developing a Public Representative Network Report of public representative networking event, 20 th February 2017 Contents Developing a Public Representative Network... 2 Summary... 2 1. Background... 2
More informationBusiness Development Strategy and Intelligence JOB CODE DEPARTMENT Business Development DATE REVIEWED 13/06/2016 LOCATION EMPLOYMENT STATUS
1. POSITION DETAIL CURRENT JOB TITLE Business Intelligence JOB GRADE D4 PROPOSED JOB TITLE Business Development Strategy and Intelligence JOB CODE DEPARTMENT Business Development DATE REVIEWED 13/06/2016
More informationPanelists 11/16/2017. Defining Patient Engagement in Research: A Qualitative Analysis. ISPOR Patient Centered Special Interest Group
Defining Patient Engagement in Research: A Qualitative Analysis ISPOR Patient Centered Special Interest Group Open Meeting ISPOR 20th Annual European Congress 7 November 2017 Glasgow, Scotland Panelists
More informationB.I.R.O. Best Information through Regional Outcomes
B.I.R.O. Best Information through Regional Outcomes The role of BIRO in the implementation of the Diabetes EU Policy Recommendations Fabrizio Carinci, BIRO Technical Coordinator, University of Perugia
More informationComparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS
Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS ASSESSING NETWORK META ANALYSIS STUDIES: A PROPOSED MEASUREMENT
More informationResearch for Development Impact Network
Research for Development Impact Network Mid-term Review of Research for Development Impact (RDI) Network Program Executive Summary and Management Response Submitted: 11 July 2017 This report has been prepared
More informationReport to the Merton Clinical Commissioning Group Governing Body
MCCG Board : 27.09.12 Pt1 : 7.5 : Att 11 Report to the Merton Clinical Commissioning Group Governing Body Date of Meeting: Thursday, 27 th Agenda No: 7.5 ATTACHMENT 11 Title of Document: Implementation
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationTitle Corporate Parenting Plan
Title Corporate Parenting Plan Sub-title 2017-18 Introduction NHS Education for Scotland (NES) is a national special health board. In NHSScotland, there are fourteen territorial health boards delivering
More informationJob Description & Person Specification Palliative Care Research Network Project Manager
Job Description & Person Specification Palliative Care Research Network Project Manager Job Title: Project Manager (0.5WTE Specified Purpose Contract) Accountable to: Head of Institute of All Ireland Institute
More informationREGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN?
REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN? Rosanna Tarricone, PhD Associate Dean, Government Health and Non Profit Division Issue Panel Opportunities and challenges in international
More informationGetting Emerging Planning Professionals Started: What We re All About. Draft for Discussion
Getting Emerging Planning Professionals Started: What We re All About Draft for Discussion Table of Contents Introduction...2 Background...2 Membership...2 Vision and Mission Statements...3 Goals and Objectives...3
More informationPatient engagement: The future for outcomes research and clinical trials?
Polling and Q&A WiFi Network: ISPORGlasgow Password: IQVIA2017 https://myispor.cnf.io/ Step 2 ISPOR Congress Platform Step 3: Please select workshop W16 Tuesday 7 th November, 4.45pm Mobile App Search
More informationAccess to newly licensed medicines. Scottish Medicines Consortium
Access to newly licensed medicines Scottish Medicines Consortium Modifiers The Committee has previously been provided with information about why the SMC uses modifiers in its appraisal process and also
More informationAmerican College of Healthcare Executives 2018 Chapter Development Report Division of Regional Services March 2018
American College of Healthcare Executives 2018 Chapter Development Report Division of Regional Services March 2018 Since the establishment of chapters in 2004 the Chapter Development Report has tracked
More information7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES
7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES 13-14 June 2018 Dublin, Ireland WHY Since the Avoca Quality Consortium (AQC) launched seven years ago, its mission and purpose has been to
More informationALBERTA CLINICAL RESEARCH CONSORTIUM Strategic Plan Phase II STRATEGIC PLAN PHASE II
ALBERTA CLINICAL RESEARCH CONSORTIUM Strategic Plan Phase II 2018-2020 STRATEGIC PLAN PHASE II 1 Our vision is high quality, integrated, and efficient clinical health research in Alberta ALBERTA CLINICAL
More information@BWHiHub. How Harnessing the Power of Technology and Innovation can Improve Health Outcomes, Global Health and Health Systems
How Harnessing the Power of Technology and Innovation can Improve Health Outcomes, Global Health and Health Systems Adam Landman, MD, MS, MIS, MHS Public Health Leadership Forum Massachusetts Medical Society
More informationComparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS
Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS HEALTH EVIDENCE FOR DECISION MAKING: ASSESSMENT TOOL
More informationUpdated Activity Work Plan : Drug and Alcohol Treatment
Web Version HPRM DOC/17/1043 Updated Activity Work Plan 2016-2019: Drug and Alcohol Treatment This Drug and Alcohol Treatment Activity Work Plan template has the following parts: 1. The updated strategic
More informationHealthier together The Greater Manchester experience
case service redesign study March 2013 No. 2 The Greater Manchester experience Key points Key to managing the review has been early engagement with a wide group of stakeholders: patients and the public,
More informationStrategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network
Strategic Operational Research Plan 2017-2018 February 13, 2017 Digestive Health Strategic Clinical Network DH SCN Strategic Operational Plan The of the Digestive Health Strategic Clinical Network The
More informationPRO-CHOICE PUBLIC EDUCATION PROJECT (PEP) STRATEGIC PLAN
PRO-CHOICE PUBLIC EDUCATION PROJECT (PEP) STRATEGIC PLAN 2010-2012 INTRODUCTION PEP entered 2009 with the energy and optimism that the 2008 elections had reawakened in communities and individuals across
More informationConsumer Participation Strategy
Consumer Participation Strategy Plan Implementation Period 2011-2013 Date: 24 December 2010 Developed by: NEMICS Directorate in consultation with Acknowledgements and thank you to: s, Dr Ian Roos (Cancer
More informationBusiness Plan. July 2016 to June Trusted evidence. Informed decisions. Better health.
Business Plan July 2016 to June 2017 Trusted evidence. Informed decisions. Better health. Business Plan for Cochrane Australia (2016-2017) 2 Cochrane vision Our vision is a world of improved health where
More informationThe Journey towards Total Wellbeing A Health System s Innovative Approach
The Journey towards Total Wellbeing A Health System s Innovative Approach Company Profile Wellness A state of complete physical, mental and social wellbeing and not merely the absence of disease or infirmity
More informationMonthly Campaign Webinar. May 19, 2016
Monthly Campaign Webinar May 19, 2016 WEBINAR REMINDERS Webinar will be recorded today and available the week of May 23 rd Together2Goal.org Website (Improve Patient Outcomes Webinars) Email distribution
More informationA voice for positive change in NHS Wales
A voice for positive change in NHS Wales Foreward from Director Helen Birtwhistle The past 12 months have proved to be another busy year for NHS Wales. There is no doubt that with elections on the horizon
More informationCADTH SYMPOSIUM 2016 Scott Gavura, Director, Provincial Drug Reimbursement Programs
Cancer Drug Funding Sustainability: From Recommendations to Action CADTH SYMPOSIUM 2016 Scott Gavura, Director, Provincial Drug Reimbursement Programs Contributing authors Provincial Drug Reimbursement
More informationAND THE COMMUNITY HEALTH PARTNERSHIP INCLUDING THE HEALTH IMPROVEMENT STANDING GROUP. DATE Paper 3.7
DRAFT PARTNERSHIP AGREEMENT BETWEEN THE EDINBURGH PARTNERSHIP AND THE COMMUNITY HEALTH PARTNERSHIP INCLUDING THE HEALTH IMPROVEMENT STANDING GROUP INTRODUCTION DATE.. 2011 Paper 3.7 1. The Edinburgh Partnership
More informationHEALTHWATCH AND HEALTH AND WELLBEING BOARDS
HEALTHWATCH AND HEALTH AND WELLBEING BOARDS INTRODUCTION In April 2013 local Healthwatch organisations came into being. The national body, Healthwatch England, with clear responsibilities and powers, was
More informationDementia Friendly Communities Recognition Process. Karishma Chandaria Dementia Friendly Communities Programme Manager
Dementia Friendly Communities Recognition Process Karishma Chandaria Dementia Friendly Communities Programme Manager Living well with dementia Development of DFCs Progress in creating dementia friendly
More informationOUR GOALS. For the detailed plan visit
STRATEGIC PRIORITIES When organizations reach milestones such as a golden anniversary, leadership should not only seize the opportunity to revel in past successes, but also proceed with a renewed focus
More informationData Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis
February, 13th 2018 Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies:
More informationTransforming health through IT
@himsseurope HIMSS Europe 02 HIMSS Europe www.himss.eu The Leading Health IT Knowledge Organisation HIMSS Europe is a voice, advisor and thought leader of transformation through health IT. As an independent
More informationRetina International General Assembly Auckland, New Zealand
Retina International General Assembly 2018 - Auckland, New Zealand Thursday, February 8th, 2018 Location: University of Auckland Business School Owen G Glenn Building, 12 Grafton Road, Auckland, 1010 Room:
More informationAction plan template for national governing bodies of sport
Mental Health Charter for Sport and Recreation The next steps Action plan template for national governing bodies of sport As a signatory of the Mental Health Charter for Sport and Recreation we are committed
More informationThe Pharmacy Quality Alliance Optimizing Health by Advancing the Quality of Medication Use
Optimizing Health by Improving the Quality of Medication Use Adult Immunization Measure Development Update The Optimizing Health by Advancing the Quality of Medication Use Lisa Hines, PharmD Senior Director,
More informationNational Group for Volunteering in NHS Scotland
National Group for Volunteering in NHS Scotland Minutes of the meeting held on Tuesday 15 November 2016 Crammond Room, Scottish Health Services Centre, Edinburgh. Present Neil Galbraith Alan Bigham Rob
More informationThe Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016
The Prime Minister s Challenge on Dementia 2020 1 Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016 Costs and impact of dementia Estimated 676,000 people in England with
More informationTerms of Reference for the Clinical Board of the Pumping Marvellous Foundation
Terms of Reference for the Clinical Board of the Pumping Marvellous Foundation The terms of reference for the Clinical Board of the Pumping Marvellous Foundation are in place to ensure a clear understanding,
More informationDriving Improvement in Healthcare Our Strategy
Driving Improvement in Healthcare Healthcare Improvement Scotland 2014 First published April 2014 The contents of this document may be copied or reproduced for use within NHSScotland, or for educational,
More informationProcess for End of Life and Very Rare Conditions (orphan and ultra-orphan medicines)
PACE (Patient & Clinician Engagement) Overview Document Process for End of Life and Very Rare Conditions (orphan and ultra-orphan medicines) Introduction The Scottish Medicines Consortium (SMC) has changed
More informationConsumer Participation Plan Summary
Consumer Participation Plan Summary 2013-2016 Table of Contents 1. Summary... 1 6. Consumer, Carer and Community Participation Plan... 3 6.1 Aim... 3 6.2 Objectives... 3 6.3 Strategies... 4 7. Strategies
More informationElectronic Capture of PROs in NCI Clinical Trials
Electronic Capture of PROs in NCI Clinical Trials Lori Minasian, MD, FACP Deputy Director, Division of Cancer Prevention, NCI July 27, 2017 Vision for PROs in NCI Clinical Trials Incorporate patient reported
More informationEUPATI beyond January 2017 Nicola Bedlington and the EUPATI Team
EUPATI beyond January 2017 Nicola Bedlington and the EUPATI Team The EUPATI journey so far what have we achieved after 5 years? A trusted and credible public-private partnership between patient organisations,
More informationStudy Endpoint Considerations: Final PRO Guidance and Beyond
Study Endpoint Considerations: Final PRO Guidance and Beyond Laurie Burke Associate Director for Study Endpoints and Labeling OND/CDER/FDA Presented at: FIRST ANNUAL PATIENT REPORTED OUTCOMES (PRO) CONSORTIUM
More informationAccelerating Patient-Centered Outcomes Research and Methodological Research
Accelerating Patient-Centered Outcomes Research and Methodological Research Jason Gerson, PhD CER Methods JSM 2016 July 31, 2016 In This Session PCORI Overview Methods Program Overview Methods Program
More informationCancer Immunotherapy from the Health Technology Assessment (HTA) and Payer Perspectives
BBS PSI Scientific Meeting: Empower the immune system to fight cancer Cancer Immunotherapy from the Health Technology Assessment (HTA) and Payer Perspectives Fred Sorenson, Xcenda Disclaimer and Acknowledgements
More informationNHC Webinar Series on Clinical Outcome Assessments. Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference?
NHC Webinar Series on Clinical Outcome Assessments Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference? NOVEMBER 7, 2018 Outline Why are we having this webinar? Introduction
More informationStatistical Analysis Plans
Statistical Analysis Plans PROFESSOR CARROL GAMBLE UNIVERSITY OF LIVERPOOL Clinical Trials Lots of different types of clinical trials Various interventions Pharmaceutical/drugs regulated Regulated environment
More informationProgramme Analyst Adolescents and Youth. Duty Station: The Gambia. DHR Director Date: August 2017
JOB DESCRIPTION Official Job Title: Grade (Classified) Programme Analyst Adolescents and Youth Duty Station: The Gambia NO-B Post Number: 00123852 Post Type: Rotational Non-Rotational Classification Authority:
More informationA proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa
A proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa 27 October 2015 Table of contents Introduction... 3 Overview of the Association of
More informationThe EQUATOR Network: a global initiative to improve the quality of reporting research
The EQUATOR Network: a global initiative to improve the quality of reporting research Author behaviour concerning publishing health research (1) A journal received a submission it had already rejected
More informationJayna Holroyd-Leduc, MD, FRCPC Associate Professor, Section of Geriatrics, U of Calgary Co-Chair of TVN s Citizen Engagement Initiative
Jayna Holroyd-Leduc, MD, FRCPC Associate Professor, Section of Geriatrics, U of Calgary Co-Chair of TVN s Citizen Engagement Initiative Giving Voice to Frail Elderly Canadians Initiative Led by members
More informationEuroHealthNet. EU Compass for Action on Mental health & Well-being. EUREGHA seminar: Mental Health in the Young 27 April 2017
EuroHealthNet EU Compass for Action on Mental health & Well-being EUREGHA seminar: Mental Health in the Young 27 April 2017 Claudia Marinetti Programme Manager About EuroHealthNet Objectives Reducing Health
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationPatient and Public Involvement in JPND Research
Patient and Public Involvement in JPND Research A user-friendly guide for applicants to JPND Calls for proposals January 5 2015 Created in conjunction with DenDRoN, United Kingdom Purpose The purpose of
More information2.2 The primary roles and responsibilities of the Committee are to:
Edinburgh Child Protection Constitution 1. Introduction 1.1 This document sets out the governance arrangements established to promote the delivery of integrated, high quality child protection services
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit Contract number: 2010 21 02 Acronym: QUANDHIP INTERIM REPORT 02_2013 Proposal title: Quality
More information2018 AFP INTERNATIONAL COMMITTEE DESCRIPTIONS
2018 AFP INTERNATIONAL COMMITTEE DESCRIPTIONS MEMBERSHIP SERVICES DIVISION Leadership Development and Member Engagement: Ensures AFP services to members and provides support to chapters and chapter services.
More informationImproving reporting for observational studies: STROBE statement
Improving reporting for observational studies: STROBE statement Technical meeting on the reporting of human studies submitted for the scientific substantiation of health claims EFSA Parma 20 November 2013
More informationCTFPHC Working Group Members:
Cognitive Impairment - Guideline Presentation Speaker deck OVERVIEW We will review the following: 1. Background on Cognitive Impairment 2. Methods of the CTFPHC 3. Recommendations and Key Findings 4. Implementation
More informationHIMSS Corporate Membership Benefits
Engage the industry and become a catalyst for progress HIMSS Corporate Membership Benefits North America www.himss.org Strengthen Brand Credibility Utilize a HIMSS member USPS mailing list, targeted by
More informationComprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP
Comprehensive Cancer Control Technical Assistance Training and Communication Plan PI: Mandi Pratt-Chapman, MA Cooperative Agreement #1U38DP004972-01 July 2014 Acknowledgement: This work was supported by
More informationCommunity wellbeing Voice of the User report: Summary for stakeholders
Community wellbeing Voice of the User report: Summary for stakeholders What Works Centre for Wellbeing, Community wellbeing evidence programme December 2015 This short report summarises the stakeholder
More informationESPA Directorate KPI Report: Quarter 1,
ESPA Directorate KPI : 2015 2016 Quarter 1, Compiled by ESPA Operations Manager The Key Performance Indicators (KPIs) detailed in this report give direction to the ESPA Directorate and its activities.
More informationRD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS
RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS Stakeholder Group Interest in RD-Action Dissemination purpose Channels of Dissemination (WHO) (WHY) (WHY) (HOW) Partners of RD-Action & members
More informationNew Officers Briefing Day
New Officers Briefing Day 2013 Contents RSC - Strategy and Governance RSC Networks Information for RSC Officers Finance Events Resources Communication Press and Media Important Dates Mission Objectives
More informationCJSP: On Reaffirming a Canadian School Psychology
748212CJSXXX10.1177/0829573517748212Canadian Journal of School PsychologyEditorial editorial2017 Editorial CJSP: On Reaffirming a Canadian School Psychology Canadian Journal of School Psychology 1 5 The
More informationMEASURING PATIENT AND OBSERVER-REPORTED OUTCOMES (PROS AND OBSROS) IN RARE DISEASE CLINICAL TRIALS - EMERGING GOOD PRACTICES TASK FORCE
MEASURING PATIENT AND OBSERVER-REPORTED OUTCOMES (PROS AND OBSROS) IN RARE DISEASE CLINICAL TRIALS - EMERGING GOOD PRACTICES TASK FORCE Outline I. Introduction: Current environment of clinical research
More information